Drug recall · October 13, 2021
Betaxolol Ophthalmic Solution recall
Why: Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11
- Lots / codes
Lot 0B61A, Exp 01/31/2022
- Quantity
- 10,210 bottles
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Distributed Nationwide in the USA
- Initiated
- October 4, 2021 · Voluntary: Firm initiated
- Classified
- October 7, 2021
- Reported
- October 13, 2021
- Ended
- August 17, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Betaxolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.